Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A recent SEC filing shows Tabor Asset Management increasing its stake in Madison Square Garden Sports, underscoring a...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
A striking insider move from Elevance Health’s chairman raises questions for investors. This article breaks down what...
A growing number of couples are missing coordinated claiming strategies, shaving hundreds of dollars from lifetime So...
A software engineer stands on the cusp of a potential million tax-free gain startup under QSBS rules, but a five-year...
A new chapter at Berkshire Hathaway starts with a bold Alphabet bet. This article breaks down why berkshire hathaway'...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...